Author:
Wenz Benjamin, ,Nielsen Stine,Gassowski Martyna,Santos-Hövener Claudia,Cai Wei,Ross R. Stefan,Bock Claus-Thomas,Ratsch Boris-Alexander,Kücherer Claudia,Bannert Norbert,Bremer Viviane,Hamouda Osamah,Marcus Ulrich,Zimmermann Ruth
Funder
The German Federal Ministry of Health
Robert Koch Institute
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference78 articles.
1. Hope VD, Eramova I, Capurro D, Donoghoe MC. Prevalence and estimation of hepatitis B and C infections in the WHO European region: a review of data focusing on the countries outside the European union and the European free trade association. Epidemiol Infect. 2014;142(2):270–86.
2. Joint United Nations Programme on HIV/AIDS (UNAIDS). UNAIDS Report on the Global AIDS Epidemic 2013. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS); 2013.
3. Wiessing L, Guarita B, Giraudon I, Brummer-Korvenkontio H, Salminen M, Cowan S. European monitoring of notifications of hepatitis C virus infection in the general population and among injecting drug users (IDUs)-the need to improve quality and comparability. Euro Surveill. 2008;13(21). Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=18884 .
4. Wiessing L, Likatavicius G, Hedrich D, Guarita B, van de Laar MJ, Vicente J. Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010. Euro Surveill. 2011;16(48):9–13.
5. Hope VD, Hickman M, Ngui SL, Jones S, Telfer M, Bizzarri M, Ncube F, Parry JV. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. J Viral Hepat. 2011;18(4):262–70.